Charles Powell, MD, chief of pulmonary, critical care, and sleep medicine at Mount Sinai in New York and chair of the American Thoracic Society’s thoracic oncology assembly is available to comment on the upcoming announcement of a preliminary decision by the Centers for Medicare & Medicaid Services to cover lung cancer screening with low dose computed tomography . “LDCT has been shown to reduce mortality when used to screen individuals who are at high risk for developing lung cancer because of their age and smoking history,” said Dr. Powell.
